Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

In collaboration with the infectious disease units at the John Radcliffe and Churchill Hospitals, the Vasudevan lab has identified a novel means of improving RT-qPCR sensitivity and efficiency for the detection of SARS-CoV-2 through the concentration of pooled patient lysates.

The SARS-CoV-2 virus has spread globally with over >95 million reported cases. Although, RT-qPCR has emerged as the gold-standard method for diagnosis, upscaling these tests to meet current demand is difficult. One means of reducing costs whilst simultaneously increasing throughput is to perform pooled testing. However, the main shortcoming of pooled testing lies in the loss of sensitivity associated with diluted samples, leading to false negative results. Here we report a new method  as a means of preserving and/or improving the sensitivity of pooled patient oro-nasopharyngeal lysates.. Comparing a spectrum of 340 COVID-19 positive and negative patients pooled lysates with individual PCR demonstrated that the loss in RT-qPCR sensitivity of pooled samples could be overcome with concentrators. We demonstrated that concentration of COVID-19 patient lysates could be successfully implemented for surveillance screening using pooling with minimal changes to standard workflow. Given that pooling reduces use of laboratory resources by up to 90% and only adds 15 minutes to the existing protocol, the described method will be indispensable for future surveillance testing. Given its simplicity, with no need for additional sophisticated instrumentation, our concentration approach could be used successfully to identify SARS-CoV-2 and other DNA/RNA pathogens (old and novel).


Similar stories

Professor Fran Platt elected to The Royal Society

We were delighted to learn from the announcement today, 6 May 2021, that Professor Fran Platt has been elected a Fellow of The Royal Society. She is one of the 52 distinguished scientists whose election was announced, and one of the two biologists out of six Oxford academics so-honoured this year.

Success for Dr Kerstin Timm with AMS Springboard grant

Dr Kerstin Timm in the Department of Pharmacology has been announced as one of the latest round of PIs to secure an AMS Springboard Award. The AMS Springboard award is highly competitive and is intended for new independent researchers in biomedical sciences, who have been in their role for less than 4 years and have not received more than £150,000 in grant money. The Springboard award thus allows new PIs to launch a new independent program of research, and awards are made for up to £100,000 over 2 years.

John Parrington launches ‘Mind Shift: How culture transformed the human brain’

A new book is published this week by Oxford University Press written by Associate Professor John Parrington. ‘Mind Shift’ draws on new scientific evidence to offer a substantive material explanation of self-conscious awareness in humans.